Search Results for 'prep oral'

prep oral published presentations and documents on DocSlides.

Addendum:   INITIATION AND CLINICAL MANAGEMENT OF ORAL  PrEP
Addendum: INITIATION AND CLINICAL MANAGEMENT OF ORAL PrEP
by faustina-dinatale
Addendum: INITIATION AND CLINICAL MANAGEMENT OF...
Module 4:  ORAL  PrEP  PROVISION FOR AGYW: GETTING STARTED  Version: August 2018
Module 4: ORAL PrEP PROVISION FOR AGYW: GETTING STARTED Version: August 2018
by aaron
Module 4: ORAL PrEP PROVISION FOR AGYW: GETTIN...
Module 3:  IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW
by sophie
Version. : June 2019. Outline of training. Module ...
Oral pre-exposure prophylaxis (PrEP) for populations at sub
Oral pre-exposure prophylaxis (PrEP) for populations at sub
by giovanna-bartolotta
Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP...
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
by giovanna-bartolotta
“On Demand” Oral PrEP: Lessons Learned from M...
Oral  PrEP  Enrollment Snapshot, June 2018
Oral PrEP Enrollment Snapshot, June 2018
by myesha-ticknor
Oral PrEP Enrollment Snapshot, June 2018 AVAC t...
CAB for PrEP for Advocates
CAB for PrEP for Advocates
by hadly
Basics of Injectable Cabotegravir. for HIV Prevent...
 OPTIONS Modeling Oral HIV Pre-exposure Prophylaxis in Zimbabwe
OPTIONS Modeling Oral HIV Pre-exposure Prophylaxis in Zimbabwe
by calandra-battersby
Zindoga. Mukandavire. 1. , . Graham F. Medley. 1...
Module 3:  IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by alida-meadow
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Module 3:  IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by tawny-fly
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Module 2:  THE PROVISION OF ORAL
Module 2: THE PROVISION OF ORAL
by pasty-toler
PrEP. . IN THE CONTEXT OF AGYW . Version: Augus...
Module 1:  INTRODUCTION TO ORAL
Module 1: INTRODUCTION TO ORAL
by pamella-moone
PrEP. Version. : December . 2018. Outline of tra...
Addendum:   INITIATION AND CLINICAL MANAGEMENT OF ORAL
Addendum: INITIATION AND CLINICAL MANAGEMENT OF ORAL
by myesha-ticknor
PrEP. Note: . AGYW should follow the same procedu...
PrEP Training for
PrEP Training for
by tatyana-admore
Providers in Clinical Settings. 2. Welcome!. Plea...
ADOLESCENT  PrEP   STUDIES
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
Situation Analysis for the Introduction of the PrEP Ring
Situation Analysis for the Introduction of the PrEP Ring
by jovita
Overview and Instructions. PLAN. 4 . RING . TOOLK...
Provider Training Package:
Provider Training Package:
by mila-milly
EFFECTIVE DELIVERY OF . ORAL PRE-EXPOSURE PROPHYLA...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
Module 6:  WRAPPING UP
Module 6: WRAPPING UP
by alexa-scheidler
Module 6: WRAPPING UP Version: August 2018 Outl...
Module 5:  MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
by calandra-battersby
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE S...
Module 5:  MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
by natalia-silvester
ON ORAL . PrEP. Version. : December 2018. Initia...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
Dapivirine  Ring Introduction Framework and Key Insights
Dapivirine Ring Introduction Framework and Key Insights
by valerie
PLAN. 4 . RING . TOOLKIT. PROMISE. Preparing for ...
What’s New & Next in
What’s New & Next in
by badra
HIV Prevention . Mitchell Warren. July 2021. Outli...
HIV Testing for Advocates
HIV Testing for Advocates
by gian628
Basics of HIV Testing and Implications for HIV Pre...
Integrating oral HIV pre-exposure prophylaxis (
Integrating oral HIV pre-exposure prophylaxis (
by elina
PrEP. ) in a public family planning facility and y...
Gaston  Djomand  (CDC) &
Gaston Djomand  (CDC) &
by ash
Chris Obermeyer (USAID). on behalf of the interage...
Optimizing  the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral te
Optimizing the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral te
by groundstimulus
PrEP. Kenneth Mugwanya, . Renee Heffron. , Christi...
P r EP  introduction
P r EP introduction
by olivia-moreira
P r EP introduction for Adolescent Girls and Yo...
Pre- and Post-Exposure Prophylaxis for HIV
Pre- and Post-Exposure Prophylaxis for HIV
by stefany-barnette
Kevin L. Ard, MD, MPH. October 20, 2016. Learning...
Adherence and Acceptability for PrEP formulations
Adherence and Acceptability for PrEP formulations
by olivia-moreira
Jessica Haberer, MD, MS. July . 24, . 2017. Confl...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Long-Acting Injectables
Long-Acting Injectables
by calandra-battersby
for PrEP. Sinead Delany-Moretlwe. University of t...